METHODS, COMPOSITIONS AND DEVICES FOR INDUCING STASIS IN TISSUES AND ORGANS
    33.
    发明申请
    METHODS, COMPOSITIONS AND DEVICES FOR INDUCING STASIS IN TISSUES AND ORGANS 审中-公开
    用于在组织和器官中诱导瘢痕的方法,组合物和装置

    公开(公告)号:WO2005041656A2

    公开(公告)日:2005-05-12

    申请号:PCT/US2004/035034

    申请日:2004-10-22

    Inventor: ROTH, Mark, B.

    CPC classification number: C12N5/00 A01N1/02 A01N1/0221 C12N2500/02

    Abstract: The present invention concerns the use of oxygen antagonists for inducing stasis in tissue, including all or part of organs. It includes methods and apparatuses for achieving stasis in tissue, so as to preserve and/or protect them. In specific embodiments, preservation methods and apparatuses for preserving tissue for transplantation purposes is provided.

    Abstract translation: 本发明涉及氧拮抗剂用于诱导组织中包括全部或部分器官停滞的用途。 它包括用于在组织中实现停滞的方法和设备,以保存和/或保护它们。 在具体实施方案中,提供了用于为移植目的保存组织的保存方法和装置。

    METHODS FOR INDUCING REVERSIBLE STASIS
    34.
    发明申请
    METHODS FOR INDUCING REVERSIBLE STASIS 审中-公开
    诱发可逆性疾病的方法

    公开(公告)号:WO2002101018A2

    公开(公告)日:2002-12-19

    申请号:PCT/US2002/018518

    申请日:2002-06-10

    IPC: C12N

    Abstract: The present invention concerns compositions and methods involving incubating biological materials under hypoxic or anoxic conditions to induce stasis or suspended animation. Methods of screening for compounds that induce stasis or compounds that increase the ability to undergo stasis are included. Such methods have ramifications for preserving biological materials as well as reducing or preventing trauma to biological materials. Also contemplated are methods for screening compounds that are active or more active under hypoxic conditions than normoxic conditions. Such methods can be used to identify antitumor compounds that would operate under hypoxic conditions in which tumor cells survive.

    Abstract translation: 本发明涉及在缺氧或缺氧条件下培养生物材料以诱导淤滞或悬浮动画的组合物和方法。 包括筛选引起淤滞的化合物或增加瘀血能力的化合物的方法。 这种方法具有保护生物材料以及减少或预防生物材料创伤的后果。 还考虑了用于筛选在缺氧条件下比正常氧条件下活性或更有活性的化合物的方法。 这样的方法可用于鉴定将在其中肿瘤细胞存活的缺氧条件下操作的抗肿瘤化合物。

Patent Agency Ranking